Global and United States Rheumatoid Arthritis Therapeutics Market Report & Forecast 2023-2029
Global and United States Rheumatoid Arthritis Therapeutics Market Report & Forecast 2023-2029
The Rheumatoid Arthritis Therapeutics Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The research time span covered by the report is from 2018 to 2029; it provides an overview of the Global Rheumatoid Arthritis Therapeutics Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.
The global Rheumatoid Arthritis Therapeutics market size in 2022 is 28210.0 million US dollars, and it is expected to be 38647.8 million US dollars by 2029, with a compound annual growth rate of 4.60% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Rheumatoid Arthritis Therapeutics market include Pfizer Inc., Amgen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, and UCB SA.. The share of the top 3 players in the Rheumatoid Arthritis Therapeutics market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Rheumatoid Arthritis Therapeutics market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Biologics accounted for XX% of Rheumatoid Arthritis Therapeutics market in 2022. Non-Biologics share of XX%.
Oral accounted for XX% of the Rheumatoid Arthritis Therapeutics market in 2022. Parenteral accounts for XX%.
For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.
As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.
Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.
Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.
Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, study objectives and industry dynamic analysis, and then includes the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Rheumatoid Arthritis Therapeutics market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 3-5: Segmented the global Rheumatoid Arthritis Therapeutics market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 6: Provide global Rheumatoid Arthritis Therapeutics market size and growth by region.
Chapter 7: Analyzes the main companies in the Rheumatoid Arthritis Therapeutics industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 8: Analyzes the Rheumatoid Arthritis Therapeutics Value Chain, including industrial chain and major downstream buyers.
Chapter 9: The main points and conclusions of the report.
Chapter 10: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey
Player list
Pfizer Inc.
Amgen Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd
UCB SA.
Gilead Sciences, Inc.
Types list
Biologics
Non-Biologics
Application list
Oral
Parenteral
Table of Content
1 Study Coverage
1.1 Rheumatoid Arthritis Therapeutics Product Introduction
1.2 Global Rheumatoid Arthritis Therapeutics Outlook 2018 VS 2023 VS 2029
1.3 United States Rheumatoid Arthritis Therapeutics Outlook 2018 VS 2023 VS 2029
1.4 Rheumatoid Arthritis Therapeutics Market Size, United States VS Global, 2018-2029
1.4.1 The Market Share of United States Rheumatoid Arthritis Therapeutics in Global, 2018-2029
1.4.2 The Growth Rate of Rheumatoid Arthritis Therapeutics Market Size, United States VS Global, 2018 VS 2023 VS 2029
1.5 Rheumatoid Arthritis Therapeutics Market Dynamics
1.5.1 Rheumatoid Arthritis Therapeutics Market Trends
1.5.2 Rheumatoid Arthritis Therapeutics Market Drivers
1.5.3 Rheumatoid Arthritis Therapeutics Market Challenges
1.5.4 Rheumatoid Arthritis Therapeutics Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global Rheumatoid Arthritis Therapeutics Competitor Landscape by Company
2.1 Global Rheumatoid Arthritis Therapeutics Market Size by Company
2.1.1 Top Global Rheumatoid Arthritis Therapeutics Player Ranked by Revenue (2023)
2.1.2 Global Rheumatoid Arthritis Therapeutics Revenue by Player (2018-2023)
2.2 Global Rheumatoid Arthritis Therapeutics Concentration Ratio (CR)
2.2.1 Rheumatoid Arthritis Therapeutics Market Concentration Ratio (CR) (2018-2023)
2.2.2 Global Top 3 and Top 6 Largest Players of Rheumatoid Arthritis Therapeutics in 2023
2.3 Global Rheumatoid Arthritis Therapeutics Business Distribution, Business Type
2.3.1 Global Rheumatoid Arthritis Therapeutics Players, Headquarters and Distribution
2.3.2 Players Rheumatoid Arthritis Therapeutics Business Type
2.3.3 Date of International Players Enter into Rheumatoid Arthritis Therapeutics Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States Rheumatoid Arthritis Therapeutics Market Size by Company
2.5.1 Top United States Rheumatoid Arthritis Therapeutics Player s Ranked by Revenue (2023)
2.5.2 United States Rheumatoid Arthritis Therapeutics Revenue by Player (2018-2023)
3 Rheumatoid Arthritis Therapeutics Market Segment by Type
3.1 Rheumatoid Arthritis Therapeutics Market Segment by Type
3.2 Global Rheumatoid Arthritis Therapeutics Market Size by Type
3.3 United States Rheumatoid Arthritis Therapeutics Market Size by Type
4 Rheumatoid Arthritis Therapeutics by Market Segment Application
4.1 Rheumatoid Arthritis Therapeutics Market Segment by Application
4.2 Global Rheumatoid Arthritis Therapeutics Market Size by Application
4.3 United States Rheumatoid Arthritis Therapeutics Market Size by Application
5 Global Rheumatoid Arthritis Therapeutics Market Size by Region
5.1 Global Rheumatoid Arthritis Therapeutics Market Size by Region: 2018 VS 2023 VS 2029
5.2 Global Rheumatoid Arthritis Therapeutics Market Size in Value by Region (2018-2029)
5.2.1 Global Rheumatoid Arthritis Therapeutics Revenue by Region: 2018-2023
5.2.2 Global Rheumatoid Arthritis Therapeutics Revenue by Region: 2023-2029
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Rheumatoid Arthritis Therapeutics Market Size YoY Growth 2018-2029
6.1.2 North America Rheumatoid Arthritis Therapeutics Market Facts & Figures by Country (2018-2029)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific Rheumatoid Arthritis Therapeutics Market Size YoY Growth 2018-2029
6.2.2 Asia Pacific Rheumatoid Arthritis Therapeutics Market Facts & Figures by Country (2018-2029)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe Rheumatoid Arthritis Therapeutics Market Size YoY Growth 2018-2029
6.3.2 Europe Rheumatoid Arthritis Therapeutics Market Facts & Figures by Country (2018-2029)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Rheumatoid Arthritis Therapeutics Market Size YoY Growth 2018-2029
6.4.2 Latin America Rheumatoid Arthritis Therapeutics Market Facts & Figures by Country (2018-2029)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Rheumatoid Arthritis Therapeutics Market Size YoY Growth 2018-2029
6.5.2 Middle East and Africa Rheumatoid Arthritis Therapeutics Market Facts & Figures by Country (2018-2029)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer Inc.
7.1.1 Company Details
7.1.2 Description and Business Overview
7.1.3 Rheumatoid Arthritis Therapeutics Introduction
7.1.4 Pfizer Inc. Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023)
7.1.5 Pfizer Inc. Recent Development
7.2 Amgen Inc.
7.2.1 Company Details
7.2.2 Description and Business Overview
7.2.3 Rheumatoid Arthritis Therapeutics Introduction
7.2.4 Amgen Inc. Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023)
7.2.5 Amgen Inc. Recent Development
7.3 Bristol-Myers Squibb Company
7.3.1 Company Details
7.3.2 Description and Business Overview
7.3.3 Rheumatoid Arthritis Therapeutics Introduction
7.3.4 Bristol-Myers Squibb Company Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023)
7.3.5 Bristol-Myers Squibb Company Recent Development
7.4 F. Hoffmann-La Roche Ltd
7.4.1 Company Details
7.4.2 Description and Business Overview
7.4.3 Rheumatoid Arthritis Therapeutics Introduction
7.4.4 F. Hoffmann-La Roche Ltd Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023)
7.4.5 F. Hoffmann-La Roche Ltd Recent Development
7.5 UCB SA.
7.5.1 Company Details
7.5.2 Description and Business Overview
7.5.3 Rheumatoid Arthritis Therapeutics Introduction
7.5.4 UCB SA. Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023)
7.5.5 UCB SA. Recent Development
7.6 Gilead Sciences, Inc.
7.6.1 Company Details
7.6.2 Description and Business Overview
7.6.3 Rheumatoid Arthritis Therapeutics Introduction
7.6.4 Gilead Sciences, Inc. Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023)
7.6.5 Gilead Sciences, Inc. Recent Development
8 Value Chain and Sales Channels Analysis
8.1 Rheumatoid Arthritis Therapeutics Value Chain Analysis
8.2 Rheumatoid Arthritis Therapeutics Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Legal Disclaimer
Tables & Figures:
List of Tables and Figures
Figure Rheumatoid Arthritis Therapeutics Product Picture
Table Global Rheumatoid Arthritis Therapeutics Revenue, ($), 2018 VS 2023 VS 2029
Figure Global Rheumatoid Arthritis Therapeutics Market Size 2018-2029 ($)
Table United States Rheumatoid Arthritis Therapeutics Revenue, ($), 2018 VS 2023 VS 2029
Figure United States Rheumatoid Arthritis Therapeutics Market Size 2018-2029 ($)
Figure United States Rheumatoid Arthritis Therapeutics Market Share in Global, in Value 2018-2029
Table Rheumatoid Arthritis Therapeutics CAGR in Value, United States VS Global, 2018 VS 2023 VS 2029
Table Rheumatoid Arthritis Therapeutics Market Trends
Table Rheumatoid Arthritis Therapeutics Market Drivers
Table Rheumatoid Arthritis Therapeutics Market Challenges
Table Rheumatoid Arthritis Therapeutics Market Restraints
Figure Rheumatoid Arthritis Therapeutics Report Years Considered
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Top Rheumatoid Arthritis Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table Global Rheumatoid Arthritis Therapeutics Revenue by Player, ($), 2018-2023
Table Global Rheumatoid Arthritis Therapeutics Revenue Share by Player, 2018-2023
Table Global Rheumatoid Arthritis Therapeutics Players Market Concentration Ratio (CR5)
Figure The Top 3 and 6 Largest Players of Rheumatoid Arthritis Therapeutics in the World: Market Share by Rheumatoid Arthritis Therapeutics Revenue in 2023
Table Top Players of Rheumatoid Arthritis Therapeutics in Global Market, Headquarters and Distribution
Table Players Rheumatoid Arthritis Therapeutics Business Type
Table Date of International Players Enter into Rheumatoid Arthritis Therapeutics Market
Table Players Mergers & Acquisitions, Expansion Plans
Table Top Rheumatoid Arthritis Therapeutics Players in United States Market, Ranking by Revenue (2023)
Table United States Rheumatoid Arthritis Therapeutics Revenue by Player, ($), 2018-2023
Table United States Rheumatoid Arthritis Therapeutics Revenue Share by Player, 2018-2023
Table Global Rheumatoid Arthritis Therapeutics Revenue by Type: 2023 VS 2029 ($)
Figure Global Rheumatoid Arthritis Therapeutics Market Share by Type in 2023 & 2029
Figure Global Rheumatoid Arthritis Therapeutics Revenue by Type (2018-2029) & ($)
Figure Global Rheumatoid Arthritis Therapeutics Revenue Market Share in Value by Type (2018-2029)
Table United States Rheumatoid Arthritis Therapeutics Revenue by Type: 2023 VS 2029 ($)
Figure United States Rheumatoid Arthritis Therapeutics Market Share by Type in 2023 & 2029
Figure United States Rheumatoid Arthritis Therapeutics Revenue by Type (2018-2029) & ($)
Figure United States Rheumatoid Arthritis Therapeutics Revenue Market Share in Value by Type (2018-2029)
Table Global Rheumatoid Arthritis Therapeutics Revenue by Application: 2023 VS 2029 ($)
Figure Global Rheumatoid Arthritis Therapeutics Market Share by Application in 2023 & 2029
Figure Global Rheumatoid Arthritis Therapeutics Revenue by Application (2018-2029) & ($)
Figure Global Rheumatoid Arthritis Therapeutics Revenue Market Share in Value by Application (2018-2029)
Table United States Rheumatoid Arthritis Therapeutics Revenue by Application: 2023 VS 2029 ($)
Figure United States Rheumatoid Arthritis Therapeutics Market Share by Application in 2023 & 2029
Figure United States Rheumatoid Arthritis Therapeutics Revenue by Application (2018-2029) & ($)
Figure United States Rheumatoid Arthritis Therapeutics Revenue Market Share in Value by Application (2018-2029)
Table Global Rheumatoid Arthritis Therapeutics Market Size by Region ($): 2018 VS 2023 VS 2029
Figure Global Rheumatoid Arthritis Therapeutics Market Size Market Share by Region: 2018 VS 2023 VS 2029
Table Global Rheumatoid Arthritis Therapeutics Revenue by Region (2018-2023) & ($)
Table Global Rheumatoid Arthritis Therapeutics Revenue Forecast by Region (2023-2029) & ($)
Table Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Region (2018-2029)
Figure North America Rheumatoid Arthritis Therapeutics Revenue Growth Rate 2018-2029
Table North America Rheumatoid Arthritis Therapeutics Revenue by Country (2018-2029) & ($)
Figure U.S. Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Canada Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Asia Pacific Rheumatoid Arthritis Therapeutics Revenue Growth Rate 2018-2029 ($)
Table Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Country (2018-2029) & ($)
Figure China Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Japan Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure South Korea Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure India Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Australia Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Southeast Asia Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Europe Rheumatoid Arthritis Therapeutics Revenue Growth Rate 2018-2029 ($)
Table Europe Rheumatoid Arthritis Therapeutics Revenue by Country (2018-2029) & ($)
Figure Germany Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure France Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure UK Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Italy Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Russia Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Latin America Rheumatoid Arthritis Therapeutics Revenue Growth Rate 2018-2029 ($)
Table Latin America Rheumatoid Arthritis Therapeutics Revenue by Country (2018-2029) & ($)
Figure Mexico Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Brazil Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Argentina Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue Growth Rate 2018-2029 ($)
Table Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Country (2018-2029) & ($)
Figure Turkey Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure Saudi Arabia Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Figure UAE Rheumatoid Arthritis Therapeutics Revenue Growth Rate (2018-2029) & ($)
Table Pfizer Inc. Company Details
Table Description and Business Overview
Table Rheumatoid Arthritis Therapeutics Introduction
Table Pfizer Inc. Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Pfizer Inc. Recent Development
Table Amgen Inc. Company Details
Table Description and Business Overview
Table Rheumatoid Arthritis Therapeutics Introduction
Table Amgen Inc. Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Amgen Inc. Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Description and Business Overview
Table Rheumatoid Arthritis Therapeutics Introduction
Table Bristol-Myers Squibb Company Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Bristol-Myers Squibb Company Recent Development
Table F. Hoffmann-La Roche Ltd Company Details
Table Description and Business Overview
Table Rheumatoid Arthritis Therapeutics Introduction
Table F. Hoffmann-La Roche Ltd Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table F. Hoffmann-La Roche Ltd Recent Development
Table UCB SA. Company Details
Table Description and Business Overview
Table Rheumatoid Arthritis Therapeutics Introduction
Table UCB SA. Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table UCB SA. Recent Development
Table Gilead Sciences, Inc. Company Details
Table Description and Business Overview
Table Rheumatoid Arthritis Therapeutics Introduction
Table Gilead Sciences, Inc. Rheumatoid Arthritis Therapeutics Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Gilead Sciences, Inc. Recent Development
Figure Rheumatoid Arthritis Therapeutics Value Chain
Table Major Customers of Rheumatoid Arthritis Therapeutics with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Research Methodology:
Rheumatoid Arthritis Therapeutics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|